Author details

Full Name

Martin Sill

Affiliation

ORCID

Career Start Year

2008

Papers

117

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37875569	Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.	Nat Med	2024
36916248	Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study.	Neuro Oncol	2023
36437415	Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-isÂ a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.	Acta Neuropathol	2023
36377252	Clinical implementation of integrated molecular-morphologic risk prediction for meningioma.	Brain Pathol	2023
37679810	Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours.	Genome Med	2023
38026572	Reference on copy number variations in pleomorphic xanthoastrocytoma: Implications for diagnostic approach.	Free Neuropathol	2023
37835571	The Site of Origin of Medulloblastoma: Surgical Observations Correlated to Molecular Groups.	Cancers (Basel)	2023
38001143	Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures.	Nat Commun	2023
37776353	Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics.	Acta Neuropathol	2023
36715306	Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups.	Neuro Oncol	2023
36964296	Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature.	NPJ Precis Oncol	2023
36959034	Corrigendum to 'Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry' [EurÂ JÂ Cancer 180 (2023) 71-84].	Eur J Cancer	2023
37014508	Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification.	Acta Neuropathol	2023
37188167	Clinical outcome following surgical resection and radiotherapy in adult patients with pleomorphic xanthoastrocytoma as defined by DNA methylation profiling.	Neurooncol Pract	2023
37379234	Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.	Neuro Oncol	2023
37246777	Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study.	Neuro Oncol	2023
36933012	Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.	Acta Neuropathol	2023
36542877	Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry.	Eur J Cancer	2023
36928815	Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.	Nat Med	2023
36459208	Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts.	Acta Neuropathol	2023
36786841	Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-isÂ a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.	Acta Neuropathol	2023
35012690	Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival.	Acta Neuropathol Commun	2022
36369165	Correction to: Integrated genomic analysis reveals actionable targets in pediatric spinal cord low-grade gliomas.	Acta Neuropathol Commun	2022
36163281	Integrated genomic analysis reveals actionable targets in pediatric spinal cord low-grade gliomas.	Acta Neuropathol Commun	2022
36070143	Epigenetic profiling reveals a subset of pediatric-type glioneuronal tumors characterized by oncogenic gene fusions involving several targetable kinases.	Acta Neuropathol	2022
35357562	Rapid-CNS<sup>2</sup>: rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof-of-concept study.	Acta Neuropathol	2022
36443295	DNA methylation-based classification of sinonasal tumors.	Nat Commun	2022
35977725	Anaplastic ganglioglioma-A diagnosis comprising several distinct tumour types.	Neuropathol Appl Neurobiol	2022
36575299	Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM.	NPJ Precis Oncol	2022
34077540	Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma.	Neuro Oncol	2022
34417833	PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.	Acta Neuropathol	2021
33479225	Sarcoma classification by DNA methylation profiling.	Nat Commun	2021
33739782	Atypical Teratoid/Rhabdoid Tumor (AT/RT) With Molecular Features of Pleomorphic Xanthoastrocytoma.	Am J Surg Pathol	2021
33949149	DNA methylation-based profiling of bone and soft tissue tumours: a validation study of the 'DKFZ Sarcoma Classifier'.	J Pathol Clin Res	2021
33731860	The age of adult pilocytic astrocytoma cells.	Oncogene	2021
33879448	Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial Ependymomas.	Cancer Discov	2021
33876327	Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1.	Acta Neuropathol	2021
34355256	Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors.	Acta Neuropathol	2021
33319313	Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1.	Acta Neuropathol	2021
33249490	The genetic landscape of choroid plexus tumors in children and adults.	Neuro Oncol	2021
33130881	A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR.	Neuro Oncol	2021
33175161	An extracellular vesicle-related gene expression signature identifies high-risk patients in medulloblastoma.	Neuro Oncol	2021
33336421	Accurate calling of KIAA1549-BRAF fusions from DNA of human brain tumours using methylation array-based copy number and gene panel sequencing data.	Neuropathol Appl Neurobiol	2021
33226472	Malignant transformation of a polymorphous low grade neuroepithelial tumor of the young (PLNTY).	Acta Neuropathol	2021
34618539	Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated.	J Clin Oncol	2021
34545083	Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B.	Nat Commun	2021
34536122	GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types.	Acta Neuropathol	2021
33168106	Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions.	Acta Neuropathol Commun	2020
31734728	YAP1-fusions in pediatric NF2-wildtype meningioma.	Acta Neuropathol	2020
31786093	DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment: a population-based study.	Lancet Child Adolesc Health	2020